PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,000 | -97.3% | 100 | -90.0% | 0.00% | -97.7% |
| Q1 2017 | $37,000 | +19.4% | 1,000 | 0.0% | 0.04% | +22.9% |
| Q4 2016 | $31,000 | +3.3% | 1,000 | 0.0% | 0.04% | +2.9% |
| Q3 2016 | $30,000 | 0.0% | 1,000 | 0.0% | 0.03% | 0.0% |
| Q2 2016 | $30,000 | +3.4% | 1,000 | 0.0% | 0.03% | +3.0% |
| Q1 2016 | $29,000 | -62.8% | 1,000 | 0.0% | 0.03% | -52.2% |
| Q4 2015 | $78,000 | +4.0% | 1,000 | 0.0% | 0.07% | +11.3% |
| Q3 2015 | $75,000 | -35.9% | 1,000 | 0.0% | 0.06% | -32.6% |
| Q2 2015 | $117,000 | -50.4% | 1,000 | 0.0% | 0.09% | -45.2% |
| Q1 2015 | $236,000 | +24.9% | 1,000 | 0.0% | 0.17% | +14.3% |
| Q4 2014 | $189,000 | -20.9% | 1,000 | 0.0% | 0.15% | -19.7% |
| Q3 2014 | $239,000 | +262.1% | 1,000 | 0.0% | 0.18% | +258.8% |
| Q2 2014 | $66,000 | – | 1,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |